兴齐眼药品牌怎么样 申请店铺

我要投票 兴齐眼药在滴眼液行业中的票数:715 更新时间:2026-01-28
兴齐眼药是哪个国家的品牌?「兴齐眼药」是 沈阳兴齐眼药股份有限公司 旗下著名品牌。该品牌发源于辽宁省沈阳市,由创始人刘继东在1977-03-24期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力兴齐眼药品牌出海!将品牌入驻外推网,定制兴齐眼药品牌推广信息,可以显著提高兴齐眼药产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

兴齐眼药怎么样

沈阳兴齐眼药股份有限公司是专业从事眼科药物研发、生产及销售的企业。公司成立三十多年来,秉承“经营健康、缔造光明”的企业理念,以“专心、专注、专业”的工作精神投入到人类眼健康产业。目前,公司拥有抗菌药、抗炎药、人工泪液、角膜修复药、抗疲劳药、散瞳药、手术用药、干眼治疗药等八大系列十五个产品,为眼科疾病治疗领域提供了高品质的产品。

创新是企业发展的动力和源泉。依托于企业技术中心和眼科药物工程技术研究中心,兴齐眼药建成了常规眼用制剂、即型凝胶、缓释制剂、药理与药代动力学等专业的眼科药物研究平台,具备综合的眼科药物研发创新能力。经过多年的持续创新和积累,截止到2014年,兴齐已拥有国家授权发明专利21项,国家授权外观设计专利2项,欧洲授权专利1项。

质量源于设计,优质的产品来自对细节的不断追求。2014年,兴齐眼药棋盘山工厂投入使用。工厂参照美国FDA和欧盟GMP标准设计,由设计团队、设备供应商及工程公司,通力合作建设完成。棋盘山工厂拥有滴眼剂、眼用凝胶剂、眼膏剂、眼内溶液剂、小牛血去蛋白提取物、眼用I类包材等七条生产线。

兴齐眼药营销中心设在北京,下设29个办事处,营销网络覆盖全国。兴齐眼药以客户为中心,服务于中国眼科医疗事业。2013年,兴齐眼药与中国医师协会眼科医师分会展开持续合作,资助基层一线的住院医师参加医学继续教育培训。兴齐眼药旨在通过一系列活动,鼓励广大中青年眼科医师深入钻研、不断创新,实现眼科医师整体水平的提升。

展望未来,机遇与挑战并存,日新月异的兴齐眼药将为做具有全球竞争力的眼科药物研究和制造企业坚持不懈、努力奋斗。


Shenyang Xingqi ophthalmic medicine Co., Ltd. is a company specializing in the research and development, production and sales of ophthalmic drugs. Since its establishment more than 30 years ago, the company has adhered to the enterprise philosophy of "operating health and creating brightness", and invested in the human eye health industry with the working spirit of "concentration, concentration and professionalism". At present, the company has eight series of 15 products, including antibacterial drugs, anti-inflammatory drugs, artificial tears, corneal repair drugs, anti fatigue drugs, mydriatic drugs, surgical drugs, dry eye treatment drugs, etc., providing high-quality products for the field of ophthalmic disease treatment. Innovation is the power and source of enterprise development. Relying on the center of enterprise technology and ophthalmic pharmaceutical engineering technology research center, Xingqi eye drops has been established as a research platform for ophthalmic drugs, including conventional ophthalmic preparation, instant gel, sustained release preparation, pharmacology and pharmacokinetics. After years of continuous innovation and accumulation, by 2014, Xingqi had 21 national authorized invention patents, 2 national authorized design patents and 1 European authorized patent. Quality comes from design, and quality products come from the constant pursuit of details. In 2014, Xingqi eye medicine Qishan factory was put into use. The factory is designed according to the US FDA and EU GMP standards, and completed by the design team, equipment suppliers and engineering companies. Chessboard Hill factory has eyedrops, ophthalmic gel, eye ointment, eye solution, calf blood protein extract, eye class I packaging and other seven production lines. Xingqi eye medicine marketing center is located in Beijing, with 29 offices and marketing network covering the whole country. Xingqi eye medicine is customer-centered and serves the ophthalmic medical industry in China. In 2013, Xingqi eye medicine launched continuous cooperation with ophthalmologist branch of Chinese Medical Doctor Association to support residents at the grassroots level to participate in medical continuing education and training. Through a series of activities, Xingqi eye medicine aims to encourage young and middle-aged ophthalmologists to further study and innovate, so as to improve the overall level of ophthalmologists. Looking forward to the future, opportunities and challenges coexist, and Xingqi ophthalmic will make unremitting efforts to be a globally competitive ophthalmic drug research and manufacturing enterprise.

本文链接: https://brand.waitui.com/1af9be86f.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

高盛:3.6万亿增量资金料流入中国股市

2026年,高盛在亚太区内“超配”中国股票。高盛首席中国股票策略分析师刘劲津28日指出,盈利增长是驱动今年中国股票上涨的主要原因,同时他称,不计外资,预计将有3.6万亿规模的增量资金流入中国股市,当中部分资金经“沪深港通”流入港股市场。据高盛估算,2026年国内的个人投资者出于增加股票配置的考虑,将有约2万亿资金流入股市;机构层面,以保险公司增配权益类资产带动为核心,将有约1.6万亿元资金流入中国股票。(财新)

37分钟前

SK海力士全年营业利润47.2万亿韩元,继续评估美国上市等方案

SK海力士1月28日公布全年营业利润47.2万亿韩元,全年销售额97.1万亿韩元;四季度营业利润为19.17万亿韩元,销售额32.83万亿韩元。该公司在监管文件中表示,正持续评估各种提升公司价值的方案,包括可能在美国上市,尚未做出最终决定。(界面)

37分钟前

科华生物:控股子公司天隆公司有尼帕病毒检测整体解决方案

36氪获悉,科华生物在互动平台表示,公司控股子公司天隆公司有尼帕病毒检测整体解决方案,可支持海关、疾控中心等关键防控节点。

37分钟前

之江生物:公司尼帕病毒核酸试剂盒具有CE认证

36氪获悉,之江生物在互动平台表示,公司开发的尼帕病毒核酸测定试剂盒具有CE认证,可在欧盟国家及认可CE的相关国家地区进行销售。并且基于尼帕病毒核酸测定试剂盒及配套自动化设备,构建了全自动负压检测方案,可助力海关、疾控等部门提供精准高效的防控支持。

37分钟前

京东已注册多枚京东产发商标

36氪获悉,近日,港交所官网显示,京东智能产发股份有限公司再次提交上市申请书,美银证券、高盛及海通国际担任联席保荐人。爱企查App显示,北京京东叁佰陆拾度电子商务有限公司已成功注册多枚“京东产发”商标,国际分类涉及广告销售、网站服务、金融物管等。

37分钟前

本页详细列出关于兴齐眼药的品牌信息,含品牌所属公司介绍,兴齐眼药所处行业的品牌地位及优势。
咨询